Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of thes...
Main Authors: | Nölting, S, Grossman, AB |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2012
|
פריטים דומים
-
Pheochromocytomas and paragangliomas: assessment of malignant potential.
מאת: Korevaar, T, et al.
יצא לאור: (2011) -
Pheochromocytomas and paragangliomas: assessment of malignant potential
מאת: Korevaar, T, et al.
יצא לאור: (2011) -
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
מאת: Nölting, S, et al.
יצא לאור: (2019) -
Pheochromocytomas and secreting paragangliomas
מאת: Gimenez-Roqueplo Anne-Paule, et al.
יצא לאור: (2006-12-01) -
Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
מאת: Kaltsas, G, et al.
יצא לאור: (2003)